Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 微生物學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30613
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor黃慶璨
dc.contributor.authorTsai-Shin Chiangen
dc.contributor.author蔣采昕zh_TW
dc.date.accessioned2021-06-13T02:10:11Z-
dc.date.available2012-07-03
dc.date.copyright2007-07-03
dc.date.issued2007
dc.date.submitted2007-06-26
dc.identifier.citation1. Ackroyd, R., C. Kelty, N. Brown, and M. Reed. 2001. The history of photodetection and photodynamic therapy. Photochemistry and Photobiology. 74:656-69.
2. Allison, D. G., and P. Gilbert. 1995. Modification by surface association of antimicrobial susceptibility of bacterial populations. Journal of Industrial Microbiology. 15:311-7.
3. Anderl, J. N., J. Zahller, F. Roe, and P. S. Stewart. 2003. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrobial Agents and Chemotherapy. 47:1251-6.
4. Bachmann, B., J. Knuver-Hopf, B. Lambrecht, and H. Mohr. 1995. Target structures for HIV-1 inactivation by methylene blue and light. Journal of Medical Virology. 47:172-8.
5. Bagnall-Reeb, H. 2004. Evidence for the use of the antibiotic lock technique. Journal of Infusion Nursing. 27:118-22.
6. Baker, A., and J. R. Kanofsky. 1992. Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochemistry and Photobiology. 55:523-8.
7. Birdsell, D. C., and E. H. Cota-Robles. 1967. Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli. Journal of Bacteriology. 93:427-37.
8. Boessmann, M., T. R. Neu, H. Horn, and D. C. Hempel. 2004. Growth, structure and oxygen penetration in particle supported autotrophic biofilms. Water Science and Technology. 49:371-7.
9. Bone, R. C., W. J. Sibbald, and C. L. Sprung. 1992. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 101:1481-3.
10. Chapman, J. D., C. C. Stobbe, M. R. Arnfield, R. Santus, J. Lee, and M. S. McPhee. 1991. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiation Research. 126:73-9.
11. Cheng, J. K., J. W. Costerton, A. P. Singh, and J. M. Ingram. 1973. Susceptibility of whole cells and spheroplasts of Pseudomonas aeruginosa to actinomycin D. Antimicrobial Agents and Chemotherapy. 3:399-406.
12. Cheng, K. J., J. M. Ingram, and J. W. Costerton. 1971. Interactions of alkaline phosphatase and the cell wall of Pseudomonas aeruginosa. Journal of Bacteriology. 107:325-36.
13. Cohen, Y. 2002. Bioremediation of oil by marine microbial mats. International of Microbiolgy. 5:189-93.
14. Coratza, G., and A. M. Molina. 1978. Enhanced sensitivity to the photodynamic effect of 3,4-benzpyrene in ethylenediaminetetraacetate -treated Escherichia coli. Journal of Bacteriology. 133:411-2.
15. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-22.
16. Coudron, P. E., and C. W. Stratton. 1995. Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. 39:66-9.
17. Creagh, T. A., M. Gleeson, D. Travis, R. Grainger, T. E. McDermott, and M. R. Butler. 1995. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence? British Journal of Urology 75:477-9.
18. Davies, D. G., M. R. Parsek, J. P. Pearson, B. H. Iglewski, J. W. Costerton, and E. P. Greenberg. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-8.
19. DiTizio V, F. G., Mittelman MW, Khoury AE, Bruce AW, DiCosmo F. 1998. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 19:1877-1884.
20. Dolan, S. 2003. Severe sepsis--a major challenge for critical care. Intensive Crit Care Nurs. 19:63-7.
21. Donlan, R. M. 2002. Biofilms: microbial life on surfaces. Emerging Infectious Diseases. 8:881-90.
22. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng. 1998. Photodynamic therapy. Journal of the National Cancer Institute. 90:889-905.
23. Dougherty, T. J., J. E. Kaufman, A. Goldfarb, K. R. Weishaupt, D. Boyle, and A. Mittleman. 1978. Photoradiation therapy for the treatment of malignant tumors. Cancer Research. 38:2628-35.
24. Ehrenberg, B., Z. Malik, and Y. Nitzan. 1985. Fluorescence spectral changes of hematoporphyrin derivative upon binding to lipid vesicles, Staphylococcus aureus and Escherichia coli cells. Photochemistry and Photobiology. 41:429-35.
25. Elasri, M. O., and R. V. Miller. 1999. Study of the response of a biofilm bacterial community to UV radiation. Applied and Environmental Microbiology. 65:2025-31.
26. Elder, M. J., F. Stapleton, E. Evans, and J. K. Dart. 1995. Biofilm-related infections in ophthalmology. Eye 9 ( Pt 1):102-9.
27. Elkins, J. G., D. J. Hassett, P. S. Stewart, H. P. Schweizer, and T. R. McDermott. 1999. Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide. Applied and Environmental Microbiology. 65:4594-600.
28. Finsen, N. R. 1901. phototherapy. Edward Arnold, London.
29. Fisher, A. M. 1946. A study on the mechanism of action of penicillin as shown by its effect on bacterial morphology. Journal of Bacteriology. 52:539-554.
30. Flemming, H. C., J. Wingender, Griegbe, and C. Mayer. 2000. Physico-chemical properties of biofilms. In: Evans L. V., editor. Biofilms: recent advances in their study and control. Amsterdam: Harwood Academic Publishers.
31. Greenfeld, J. I., L. Sampath, S. J. Popilskis, S. R. Brunnert, S. Stylianos, and S. Modak. 1995. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Critical Care Medicine. 23:894-900.
32. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. Journal of Molecular Biology. 166:557-80.
33. Hassett, D. J., J. G. Elkins, J. F. Ma, and T. R. McDermott. 1999. Pseudomonas aeruginosa biofilm sensitivity to biocides: use of hydrogen peroxide as model antimicrobial agent for examining resistance mechanisms. Methods in Enzymology. 310:599-608.
34. Haywood, A. M., and R. L. Sinsheimer. 1963. Inhibition of protein synthesis in E. coli protoplasts by actinomycin-D. Journal of Molecular Biology. 6:247-9.
35. Hoppe-Seyler, F. 1871. Med. Chem. Untersuchungen, Eberhard-Karls-Universitat, Berlin.
36. Hsi, R. A., D. I. Rosenthal, and E. Glatstein. 1999. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs 57:725-34.
37. James, G. A., L. Beaudette, and J. W. Costerton. 1995. Interspecies bacterial interactions in biofilms. Journal of Industrial Microbiology. 15:257-262.
38. Jevons, M. P., A. W. Coe, and M. T. Parker. 1963. Methicillin resistance in staphylococci. The Lancet. 1:904-7.
39. Kelly, J. F., and M. E. Snell. 1976. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. The Journal of Urology. 115:150-1.
40. Kelly, J. F., M. E. Snell, and M. C. Berenbaum. 1975. Photodynamic destruction of human bladder carcinoma. British Journal of Cancer. 31:237-44.
41. Klein, M. 1947. A Mechanism for the Development of Resistance to Streptomycin and Penicillin. Journal of Bacteriology. 53:463-467.
42. Korvick, J. A., J. E. Peacock, Jr., R. R. Muder, R. R. Wheeler, and V. L. Yu. 1992. Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol. Antimicrobial Agents and Chemotherapy. 36:620-5.
43. Kreger, B. E., D. E. Craven, and W. R. McCabe. 1980. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. American Journal of Medicine. 68:344-55.
44. Lai, J., and M. Cooney. 1999. History of photodynamic therapy. International Ophthalmology Clinics. 39:163-74.
45. Lazazzera, B. A. 2000. Quorum sensing and starvation: signals for entry into stationary phase. Current Opinion in Microbiology. 3:177-82.
46. Lee, C. F., C. J. Lee, C. T. Chen, and C. T. Huang. 2004. delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. Journal of Photochemistry and Photobiology B. 75:21-5.
47. Leive, L. 1965. Actinomycin Sensitivity in Escherichia Coli Produced by EDTA. Biochem Biophys Res Commun 18:13-7.
48. Leive, L. 1965. A Nonspecific Increase in Permeability in Escherichia Coli Produced by EDTA. Proceedings of the National Academy of Sciences of the United States of America. 53:745-50.
49. Leive, L. 1968. Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. Journal of Biology Chemistry. 243:2373-80.
50. Leive, L., V. K. Shovlin, and S. E. Mergenhagen. 1968. Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. Journal of Biology Chemistry. 243:6384-91.
51. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrobial Agents and Chemotherapy. 45:999-1007.
52. Lin, H. Y., C. T. Chen, and C. T. Huang. 2004. Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells. Applied and Environmental Microbiology. 70:6453-8.
53. Lipson, R. L., and E. J. Baldes. 1960. The photodynamic properties of a particular hematoporphyrin derivative. Archives of Dermatology. 82:508-16.
54. Losick, R., and D. Kaiser. 1997. Why and how bacteria communicate. Scientific American. 276:68-73.
55. MacAlister, T. J., J. W. Costerton, and K. J. Cheng. 1972. Effect of the removal of outer cell wall layers on the actinomycin susceptibility of a gram-negative bacterium. Antimicrobial Agents and Chemotherapy. 1:447-9.
56. MacDonald, R., M. Santa, and V. S. Brozel. 2000. The response of a bacterial biofilm community in a simulated industrial cooling water system to treatment with an anionic dispersant. Journal of Applied Microbiology. 89:225-35.
57. Maisch, T., R. M. Szeimies, G. Jori, and C. Abels. 2004. Antibacterial photodynamic therapy in dermatology. Photochemistry and Photobiology science. 3:907-17.
58. Malik, Z., H. Ladan, and Y. Nitzan. 1992. Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. Journal of Photochemistry and Photobiology B. 14:262-6.
59. Mattick, J. S., M. M. Bills, B. J. Anderson, B. Dalrymple, M. R. Mott, and J. R. Egerton. 1987. Morphogenetic expression of Bacteroides nodosus fimbriae in Pseudomonas aeruginosa. Journal of Bacteriology. 169:33-41.
60. Minnock, A., D. I. Vernon, J. Schofield, J. Griffiths, J. H. Parish, and S. B. Brown. 2000. Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrobial Agents and Chemotherapy. 44:522-7.
61. Okkerse, W. J., S. P. Ottengraf, B. Osinga-Kuipers, and M. Okkerse. 1999. Biomass accumulation and clogging in biotrickling filters for waste gas treatment. Evaluation of a dynamic model using dichloromethane as a model pollutant. Biotechnology and Bioengineering. 63:418-30.
62. Osborn, M. J., J. E. Gander, E. Parisi, and J. Carson. 1972. Mechinism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane. The Journal of Biological Chemistry. 247:3962-72.
63. Osswald, P., R. Courtes, P. Bauda, J. C. Block, J. D. Bryers, and E. Sunde. 1995. Xenobiotic biodegradation test using attached bacteria in synthetic seawater. Ecotoxicology and Environmental Safety. 31:211-7.
64. Parsek, M. R., and C. Fuqua. 2004. Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life. Journal of Bacteriology. 186:4427-40.
65. Parsek, M. R., and E. P. Greenberg. 2000. Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proceedings of the National Academy of Sciences of the United States of America. 97:8789-93.
66. Parsek, M. R., and P. K. Singh. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annual Review of Microbiology. 57:677-701.
67. Pass, H. I. 1993. Photodynamic therapy in oncology: mechanisms and clinical use. Journal of the National Cancer Institute : JNCI. 85:443-56.
68. Pitts, B., A. Willse, G. A. McFeters, M. A. Hamilton, N. Zelver, and P. S. Stewart. 2001. A repeatable laboratory method for testing the efficacy of biocides against toilet bowl biofilms. Journal of Applied Microbiology. 91:110-7.
69. Prigent-Combaret, C., O. Vidal, C. Dorel, and P. Lejeune. 1999. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. Journal of Bacteriology. 181:5993-6002.
70. Raab, O. 1900. Ueber die wirkung fluorescierender stoffe auf infusorien. Zoo Biology. 39:524-546.
71. Rywkin, S., E. Ben-Hur, Z. Malik, A. M. Prince, Y. S. Li, M. E. Kenney, N. L. Oleinick, and B. Horowitz. 1994. New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates. Photochemistry and Photobiology. 60:165-70.
72. Scherer, H. 1841. Chemisch-physiologische untersuchungen. Annalen der Chemie und Pharmacie. 40:1.
73. Schultz EM, K. A. 1928. Inactivation of Staphylococcus bacteriophage by methylene blue. Proceedings of the Society of Experimental Biology and Medicine. 26:100-101.
74. Schwartz, S. K., K. Absolon and H. Vermund. 1955. Some relationships of porphyrins, x-rays and tumours. University of Minnesota medical bulletin. 27:7-8.
75. Sen, K., and H. Nikaido. 1990. In vitro trimerization of OmpF porin secreted by spheroplasts of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 87:743-7.
76. Shih, P. C., and C. T. Huang. 2002. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. The Journal of Antimicrobial Chemotherapy. 49:309-14.
77. Smith, T. L., and W. R. Jarvis. 1999. Antimicrobial resistance in Staphylococcus aureus. Microes and Infection. 1:795-805.
78. Soukos, N. S., L. A. Ximenez-Fyvie, M. R. Hamblin, S. S. Socransky, and T. Hasan. 1998. Targeted antimicrobial photochemotherapy. Antimicrobial Agents and Chemotherapy. 42:2595-601.
79. Souli, M., and H. Giamarellou. 1998. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrobial Agents and Chemotherapy. 42:939-41.
80. Spoering, A. L., and K. Lewis. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. Journal of Bacteriology. 183:6746-51.
81. Spratt, D. A., J. Latif, L. L. Montebugnoli, and M. Wilson. 2004. In vitro modeling of dental water line contamination and decontamination. FEMS Microbiology Letters. 235:363-7.
82. Srinivasan, R., P. S. Stewart, T. Griebe, C.-I. Chen and X. Xu. 1995. Biofilm parameters influencing biocide efficacy. Biotechnology and Bioengineering. 46:553-560.
83. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. The Lancet. 358:135-8.
84. Tack, K. J., and L. D. Sabath. 1985. Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. Chemotherapy. 31:204-10.
85. Tall, B. D., H. N. Williams, K. S. George, R. T. Gray, and M. Walch. 1995. Bacterial succession within a biofilm in water supply lines of dental air-water syringes. Canadian Journal of Microbiology. 41:647-54.
86. Theraud, M., Y. Bedouin, C. Guiguen, and J. P. Gangneux. 2004. Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditions. Journal of Medical Microbiology. 53:1013-8.
87. Thudichum, J. L. 1867. Tenth report of the medical officer of the privy council. H. M. Stationary Office, London.
88. Torrijos, M., P. Sousbie, R. Moletta, and J. P. Delgenes. 2004. High COD wastewater treatment in an aerobic SBR: treatment of effluent from a small farm goat's cheese dairy. Water Science and Technology. 50:259-67.
89. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. The Lancet. 358:207-8.
90. Usacheva, M. N., M. C. Teichert, and M. A. Biel. 2001. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers in Surgery and Medicine. 29:165-73.
91. Von-Tappeiner, H. a. A. J. 1907. Die sensibilisierende wirkung fluorieszierender substanzer. Gesammte Untersuchungen uber die photodynamische Erscheinung. F. C. W. Vogel, Leipzig.
92. Von-Tappeiner, H. a. A. J. 1903. Therapeutische versuche mit fluoresezierenden stoffen. Muench Munchener Medizinische Wochenschrift. 47:2042-2044.
93. Von-Tappeiner, H. a. A. J. 1904. Uber Wirkung der photodynamischen (fluorieszierenden) stoffe auf protozoan und enzyme. Deutsches Archiv für klinische Medizin. 80:427-487.
94. Wagner, M., A. Loy, R. Nogueira, U. Purkhold, N. Lee, and H. Daims. 2002. Microbial community composition and function in wastewater treatment plants. Antonie van Leeuwenhoek. 81:665-80.
95. Wainwright, M. 1998. Photodynamic antimicrobial chemotherapy (PACT). The Journal of Antimicrobial Chemotherapy. 42:13-28.
96. Walker, J. T., D. J. Bradshaw, A. M. Bennett, M. R. Fulford, M. V. Martin, and P. D. Marsh. 2000. Microbial biofilm formation and contamination of dental-unit water systems in general dental practice. Applied and Environmental Microbiology. 66:3363-7.
97. Walters, M. C., 3rd, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrobial Agents and Chemotherapy. 47:317-23.
98. Ward, A. J., and E. K. Matthews. 1996. Cytotoxic, nuclear, and growth inhibitory effects of photodynamic drugs on pancreatic carcinoma cells. Cancer Letters. 102:39-47.
99. Watnick, P., and R. Kolter. 2000. Biofilm, city of microbes. Journal of Bacteriology. 182:2675-9.
100. Wilderer, P. A., and B. S. McSwain. 2004. The SBR and its biofilm application potentials. Water Science and Technology. 50:1-10.
101. Williams, H. N., M. L. Baer, and J. I. Kelley. 1995. Contribution of biofilm bacteria to the contamination of the dental unit water supply. The Journal of the American Dental Association. 126:1255-60.
102. Wingender, J., and H. C. Flemming. 2004. Contamination potential of drinking water distribution network biofilms. Water Science and Technology. 49:277-86.
103. Xie, H., G. S. Cook, J. W. Costerton, G. Bruce, T. M. Rose, and R. J. Lamont. 2000. Intergeneric communication in dental plaque biofilms. Journal of Bacteriology. 182:7067-9.
104. 行政院國家科學委員會光電小組。2005。雷射醫學原理及臨床應用。
105. 吳天鳴,朱延和。2003。生命會自尋出路─細菌的抗藥性。科學發展, 364:64-73。
106. 涂雅屏。2005。以螺旋藻萃取之 C-藻藍素對細菌懸浮與生物膜之光動力抑制作用。國立台灣大學,微生物與生化學研究所碩士論文。
107. 陳英琮。2006。光動力作用抑制白色念珠菌懸浮細胞與生物膜。國立台灣大學,微生物與生化學研究所碩士論文。
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30613-
dc.description.abstract不同於傳統治療方式,光動力治療 (photodynamic therapy, PDT) 是以造成細胞氧化傷害達到微生物防治的目的。然而革蘭氏陰性菌對於能抑制革蘭氏陽性菌之光感物質所引起之光毒性普遍具有抗性。故本研究利用乙二胺四乙酸 (ethylenediaminetetracetic acid, EDTA) 或溶菌酶 (lysozyme) 處理之原生質體 (spheroplasts) 或勝任細胞 (competent cells) 探討革蘭氏陽性菌與革蘭氏陰性菌於細胞壁結構與細胞膜通透性之差異,對光動力治療效果之影響,並評估此方法應用於生物膜 (biofilm) 系統之可行性。也藉由穿透式電子顯微鏡 (transmission electron microscope, TEM) 觀察微生物細胞製備成原生質體或勝任細胞後形態之改變。本研究以亞甲基藍 (methylene blue) 為光感物質,利用發光二極體產生波長為 630 ± 10 nm 紅光照射後所引起之光動力作用能抑制 108 CFU/mL 革蘭氏陽性菌 Staphylococcus aureus 與 Staphylococcus epidermidis,但對抑制相同濃度之革蘭氏陰性菌 Pseudomonas aeruginosa 與 Klebsiella pneumoniae 效果不彰,Escherichia coli 與 Enterobacter aerogenes 則具有強烈抗性無法被抑制。經由 TEM 觀察 E. coli 與 E. aerogenes 發現,正常的細胞均呈現桿狀且具備完整而連續的雙層膜,但是經 lysozyme 處理後會變得接近圓球形,且肽聚醣 (peptidoglycan) 結構被破壞,但細胞膜與外膜仍保持完整;以 EDTA 處理將導致外膜受損且結構不穩定;製備成勝任細胞後造成細胞表面不平整。革蘭氏陰性菌懸浮細胞分別製備成原生質體或勝任細胞後均可大幅提升光動力作用之殺菌效果。即使具有強烈抗性之 E. coli 與 E. aerogenes 亦能在 25 mM 亞甲基藍與 60 J/cm2 照光劑量下達到完全抑菌的效果;提高作用條件也能有效殺死 107 CFU/cm2 之 E. aerogenes 生物膜。結果顯示,細菌之細胞壁結構與細胞膜通透性確實是導致光動力殺菌效果不彰的主因。本研究所使用的方法不僅能提升光動力作用對懸浮細胞之殺菌效果,亦能用於生物膜防治,使光動力治療應用於微生物防治上更具潛力。zh_TW
dc.description.abstractPhotodynamic therapy (PDT) is based on the concept that a non-toxic dye known as a photosensitizer (PS) can be accumulated in target cells and activated by low intensity visible light of the appropriate wavelength in the presence of oxygen, and consequently the reaultant singlet oxygen and free radicals are toxic to target cells. In the 1990s, many studies have demonstrated that Gram-positive bacteria are particularly susceptible to photodynamic inactivation (PDI), while Gram-negative bacteria are significantly resistant under the same PDI condition. The major difference between the Gram-positive and Gram-negative species is the composition of cell wall. In this study, the roles of the outer membrane and peptidoglycan in the Gram-negative cell walls as well as the permeability of the cell membrane in methylene blue mediated PDI (MB-PDI) were investigated. Meanwhile, the cell structure of Gram-negative bacteria was observed by the transmission electron microscope (TEM). The Gram-negative bacterial cell walls were treated with lysozyme and EDTA to disrupt the peptidoglycan and the outer membrane, respectively. The cell membrane permeability was increased by making Gram-negative bacterial competent. No viable cells were detected when higher concentration of methylene blue (25 mM to 50 mM) and a light dose of 120 J/cm2 or more was used in Gram-positive bacteria, however, no significant antimicrobial efficacy was found in this condition for Gram-negative species. The cell wall disruption and morphologic change in cell membrane was observed by TEM after lysozyme, EDTA and competent cell treatment. The antimicrobial efficacy of MB-PDI against Gram-negative bacteria was enhanced both in planktonic cell and biofilm once the cell wall and membrane was disrupted. The results suggested that the outer membrane and the peptidoglycan play an important role in Gram-negative bacteria to make a diffusion barrier to methylene blue, and hence lead to the difference in MB-PDI efficacy between Gram-positive and Gram-negative bacteria.en
dc.description.provenanceMade available in DSpace on 2021-06-13T02:10:11Z (GMT). No. of bitstreams: 1
ntu-96-R94b47402-1.pdf: 1490978 bytes, checksum: cb7c62140c015b76031f894761f0dded (MD5)
Previous issue date: 2007
en
dc.description.tableofcontents中文摘要 iii
Abstract v
目錄 vii
表目錄 xi
圖目錄 xii
第一章 緒論 1
1 微生物的感染防治 1
1.1 微生物與人類疾病 1
1.2 抗生素治療疾病簡史與發展瓶頸 2
2 生物膜 5
2.1 生物膜的定義 5
2.2 生物膜的形成 5
2.3 生物膜的結構 8
2.4 生物膜與人類的關係 10
2.4.1 生物膜的益處 10
2.4.2 生物膜的害處 10
2.5 生物膜的防治 11
2.6 生物膜的抗藥性機轉 15
3 光動力治療 17
3.1 光動力治療之發展起源 17
3.2 光動力效應之發展起源 17
3.3 作用機制 18
3.4 作用基本要素 22
3.4.1 光源 22
3.4.2 光感物質 23
3.4.3 氧氣 23
3.5 相關應用 24
4 亞甲基藍在光動力療法之應用 25
5 勝任細胞 26
6 原生質體 26
7 研究動機與目的 27
第二章 材料與方法 30
1 菌株 30
1.1 懸浮菌體培養 30
1.2 生物膜反應器與培養 31
1.2.1 生物膜反應器 31
1.2.2 生物膜培養 31
1.2.3 生物膜定量 31
2 藥品配製 33
2.1 等張磷酸鹽緩衝溶液之配製 33
2.2 亞甲基藍母液之配製 33
3 光源設備 33
4 活菌數定量分析 33
5 懸浮細胞之原生質體製備 35
5.1 Lysozyme-spheroplasts 35
5.1.1 大腸桿菌之 Lysozyme-spheroplasts 製備 35
5.1.2 產氣腸桿菌之 Lysozyme-spheroplasts 製備 35
5.1.3 克雷伯氏菌之 Lysozyme-spheroplasts 製備 35
5.1.4 綠膿桿菌之 Lysozyme-spheroplasts 製備 35
5.2 EDTA-spheroplasts 35
5.2.1 大腸桿菌之 EDTA-spheroplasts 製備 35
5.2.2 產氣腸桿菌之 EDTA-spheroplasts 製備 36
5.1.3 克雷伯氏菌之 EDTA-spheroplasts 製備 36
5.2.4 綠膿桿菌之 EDTA -spheroplasts 製備 36
6 懸浮細胞之勝任細胞製備 36
6.1 大腸桿菌勝任細胞製備 36
6.2 產氣腸桿菌勝任細胞製備 37
6.3 克雷伯氏菌勝任細胞製備 37
6.4 綠膿桿菌勝任細胞製備 37
7 生物膜之原生質體製備 37
7.1 Lysozyme-spheroplasts 37
7.2 EDTA-spheroplasts 37
7.3 Competent cells 37
8 亞甲基藍對懸浮菌體之光動力抑制 38
9 亞甲基藍對生物膜之光動力抑制 38
10 穿透式電子顯微鏡觀察 38
10.1 負染色 (negative staining) 38
10.2 超薄切片 (thin sectioning) 38
10.3 電子顯微鏡 39
11 統計分析 39
第三章 結果與討論 40
第一部份:亞甲基藍之光動力作用對懸浮細胞之殺菌效果 40
1 亞甲基藍光動力作用對革蘭氏陽性菌之殺菌效果 40
2 亞甲基藍光動力作用對革蘭氏陰性菌之殺菌效果 43
2.1 正常懸浮細胞 43
2.2 Lysozyme-spheroplasts 49
2.3 EDTA-spheroplasts 55
2.4 勝任細胞 61
第二部份:亞甲基藍光動力作用對生物膜之殺菌效果 67
1 生物膜之培養與定量 67
1.1 金黃色葡萄球菌生物膜之累積曲線 67
1.2 產氣腸桿菌生物膜之累積曲線 67
2 亞甲基藍光動力作用對生物膜之殺菌效果 70
2.1. 革蘭氏陽性菌 70
2.2 革蘭氏陰性菌 74
3 亞甲基藍光動力作用對不同處理之產氣腸桿菌生物膜之殺菌效果 76
3.1 Lysozyme-sphroplasts 76
3.2 EDTA-sphroplasts 79
3.3 勝任細胞 82
第三部份:以穿透式電子顯微鏡觀察菌體形態之改變 85
1 大腸桿菌 85
2 產氣腸桿菌 90
第四章 結論 95
第五章 未來研究方針 96
第六章 參考文獻 97
dc.language.isozh-TW
dc.subject穿透式電子顯微鏡zh_TW
dc.subject光動力治療zh_TW
dc.subject亞甲基藍zh_TW
dc.subject原生質體zh_TW
dc.subject勝任細胞zh_TW
dc.subjectcompetent cellen
dc.subjectspheroplasten
dc.subjectmethylene blueen
dc.subjectransmission electron microscopyen
dc.subjectphotodynamic therapyen
dc.title細菌細胞壁組成對光動力治療抑制革蘭氏陽性菌與革蘭氏陰性菌效果之影響zh_TW
dc.titleEffects of the cell wall composition on the efficacy of photodynamic inactivation between Gram-positive and Gram-negative bacteriaen
dc.typeThesis
dc.date.schoolyear95-2
dc.description.degree碩士
dc.contributor.oralexamcommittee許瑞祥,鄧麗珍,陳進庭,楊啟伸
dc.subject.keyword光動力治療,亞甲基藍,原生質體,勝任細胞,穿透式電子顯微鏡,zh_TW
dc.subject.keywordphotodynamic therapy,methylene blue,spheroplast,competent cell,ransmission electron microscopy,en
dc.relation.page105
dc.rights.note有償授權
dc.date.accepted2007-06-27
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept微生物與生化學研究所zh_TW
顯示於系所單位:微生物學科所

文件中的檔案:
檔案 大小格式 
ntu-96-1.pdf
  未授權公開取用
1.46 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved